Intellia Therapeutics Inc buy Royal Bank of Canada
Start price
09.08.24
/
50%
€19.65
Target price
09.08.25
€49.44
Performance (%)
0.00%
Price
09.08.24
€19.65
Summary
This prediction is currently active. Royal_Bank_of_Canada's BUY prediction for Intellia Therapeutics Inc is currently unchanged. This prediction currently runs until 09.08.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Intellia Therapeutics Inc | 0.00% |
iShares Core DAX® | 0.393% |
iShares Nasdaq 100 | 0.394% |
iShares Nikkei 225® | 1.038% |
iShares S&P 500 | -0.046% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Royal Bank of Canada from $60.00 to $54.00. They now have an "outperform" rating on the stock.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€22.58
10.11.23
10.11.23
€65.49
10.11.24
10.11.24
-13.00%
09.08.24
09.08.24